Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting MET Receptor in Rhabdomyosarcoma: Rationale and Progress

21 Jan 2016

Abstract excerpt

MET is a tyrosine kinase receptor, which binds hepatocyte growth factor (HGF). It regulates many physiological processes and participates in the regulation of proliferation, differentiation and motility of various cells. It plays an important role in embryogenesis as well as in adult life. Aberrations within the regulatory pathways activated by MET can be one of the causes of tumor development. Recently novel...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Liver physiology and pathology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 26674534
DOI: 10.2174/1389450117666151209124123

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting MET Receptor in Rhabdomyosarcoma: Rationale and ProgressPMID 26674534Read ↗

Biology of MET: a double life between normal tissue repair and tumor progression.Semantic proximity Read ↗

Validation of Met as a Therapeutic Target in Alveolar and Embryonal RhabdomyosarcomaSemantic proximity Read ↗

HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted TherapySemantic proximity Read ↗

Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunitiesSemantic proximity Read ↗

Effects of PAX3-FKHR on malignant phenotypes in alveolar rhabdomyosarcoma.Semantic proximity Read ↗

MET Activation in Lung Cancer and Response to Targeted TherapiesSemantic proximity Read ↗

Role of c-MET in upper aerodigestive malignancies--from biology to novel therapies.Semantic proximity Read ↗

MET receptor tyrosine kinase as a therapeutic anticancer target.Semantic proximity Read ↗

Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems.Semantic proximity Read ↗

Cancer therapy: can the challenge be MET?Semantic proximity Read ↗

HGF/MET Signaling in Malignant Brain TumorsSemantic proximity Read ↗

From Concept to Reality: The Long Road to c-Met and RON Receptor Tyrosine Kinase Inhibitors for the Treatment of CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.